QLT, Inc. (QLTI) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/18/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Medifast launches Trilivy, replacing its Optavia brand
- Adobe has received a takeover approach by a Big Tech company - Betaville
QLT Announces Third Quarter 2014 Results
October 28, 2014 7:00 AM EDTVANCOUVER, British Columbia, Oct. 28, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq: QLTI) (TSX: QLT) ("QLT" or the "Company") is a biotechnology company dedicated to the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. The Company reported financial results today for the third quarter ended September 30, 2014. Unless otherwise specified, all amounts are reported in U.S. dollars and in accordance with U.S. GAAP.
2014 THIRD QUARTER FINANCIAL RESULTS
QLT Expenses
Research... More
QLT Appoints Dr. Geoffrey F. Cox as Interim Chief Executive Officer
October 24, 2014 7:00 AM EDTVANCOUVER, British Columbia, Oct. 24, 2014 (GLOBE NEWSWIRE) -- QLT Inc. (Nasdaq: QLTI) (TSX: QLT) ("QLT" or the "Company") today announced that current QLT Board member, Geoffrey F. Cox, Ph.D., has been appointed interim Chief Executive Officer, effective immediately. Dr. Cox brings more than 35 years of business and scientific leadership in the pharmaceutical and biotechnology industries to QLT, 13 years of which have been as Chairman and CEO of public companies. Dr. Cox will continue in his role as a member of the QLT Board of Directors. In conjunction with Dr. Cox's... More
